首页> 外国专利> METHOD OF CONTROLLING IRRADIATION EFFICIENCY OF DONOR BLOOD BY LYMPHOCYTE ACTIVATION REACTION ASSAY

METHOD OF CONTROLLING IRRADIATION EFFICIENCY OF DONOR BLOOD BY LYMPHOCYTE ACTIVATION REACTION ASSAY

机译:淋巴细胞活化反应测定控制供体血液辐射效率的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely transfusiology, and can be used to monitor efficiency of donor blood irradiation. Method involves placement of blood cell blast-transformation reaction with mitogen assay and accounting reaction results by determining lymphocyte stimulation index. Carrying out a reaction is carried out in respect to irradiated donor blood, results accounting is made with help of flow cytofluorometer using monoclonal antibodies, marked different staining, gating of activated lymphocytes with reduced expression of marker general leukocytal CD45 and determining among them percentage of double-negative T-lymphocytes with an immunophenotype CD3+CD4-CD8-, wherein unexposed sample is taken from same blood. Then efficiency of radiation is determined from ratio of content of double-negative T-lymphocytes with immunophenotype CD3+CD4-CD8- in tested irradiated and same unirradiated control blood as Eir=Sdntlo-Sdntlk, where Eir is radiation efficiency Sdntlo is percentage content of double-negative T-lymphocytes with immunophenotype CD3+CD4-CD8- in test (in irradiated tested blood), Sdntlk is percentage content of double-negative T-lymphocytes with immunophenotype CD3+CD4-CD8- in control (unirradiated sample of same blood). If difference with control is more than 50 %, conclusion is made of functional disability of T-lymphocytes in irradiated blood and immunological safety of given blood preparation for recipient.;EFFECT: using given method enables to determine effectiveness of irradiation of donor blood by flow cytometry.;1 cl
机译:领域:药物;发明:本发明涉及医学,即转融合学,并且可以用于监测供体血液照射的效率。该方法涉及通过有丝分裂原测定法放置血细胞胚细胞转化反应,并通过确定淋巴细胞刺激指数来计算反应结果。对辐照的供血者进行反应,借助流式细胞仪使用单克隆抗体对结果进行核算,显着不同的染色,对活化的淋巴细胞进行门控,标记普通白细胞CD45的表达降低,并确定其中的两倍免疫表型为CD3 + CD4-CD8-的阴性T淋巴细胞,其中未暴露的样品取自相同的血液。然后从测试的受辐照和未辐照的对照血液中具有免疫表型CD3 + CD4-CD8-的双阴性T淋巴细胞的含量之比确定辐射效率,其中Eir = Sdntlo-Sdntlk,其中Eir是辐射效率Sdntlo是百分比免疫表型为CD3 + CD4-CD8-的双阴性T淋巴细胞(在受辐照的血液中),Sdntlk为对照表中免疫表型为CD3 + CD4-CD8-的双阴性T淋巴细胞的百分比含量(相同血液的未辐照样品) )。如果与对照的差异超过50%,则得出结论是受辐照血液中T淋巴细胞的功能障碍以及给定血液制剂对接受者的免疫安全性;效果:使用给定方法可以通过血流确定供体血液辐照的有效性细胞计数法; 1 cl

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号